Vidaur, Loreto
Guridi, Amalur
Leizaola, Oihana
Marin, Jokin
Rello, Jordi
Sarasqueta, Cristina
Sorarrain, Ane
Marimón, Jose María
Funding for this research was provided by:
Instituto de Salud Carlos III (FIS17/01463, FIS17/01463)
Article History
Received: 22 August 2024
Accepted: 20 February 2025
First Online: 5 May 2025
Declarations
:
: The study was approved by the regional (Gipuzkoa) Ethics Committee, reference MOZ-NBI-2017–01. Written informed consent was given by patients or their legal representatives.
: Not applicable.
: JR received consulting fees/speaking bureau from Merck, Pfizer and Roche. All the rest of the authors declare that they have no competing interests.